Intelligence · Clinical Pipeline
Kura Oncology Pipeline
All ClinicalTrials.gov programs at Kura Oncology — phase, modality, and trial IDs.
- Programs
- 10
Quick answer
Kura Oncology has 10 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Cytarabine
Kura Oncology
Acute Myeloid Leukemia
1 trial -
Dexamethasone
Kura Oncology
Lymphoblastic Leukemia
1 trial -
Tipifarnib
Kura Oncology
HRAS Gene Mutation
1 trial -
Tipifarnib
Kura Oncology
Leukemia, Myelomonocytic, Chronic
1 trial -
Tipifarnib
Kura Oncology
Myelodysplastic Syndromes
1 trial -
Tipifarnib
Kura Oncology
Thyroid Cancer
1 trial -
Tipifarnib
Kura Oncology
Relapsed or Refractory Peripheral T-Cell Lymphoma
1 trial -
Tipifarnib
Kura Oncology
HNSCC
1 trial -
Ziftomenib
Kura Oncology
Advanced Malignant Neoplasm
1 trial -
Ziftomenib, Ziftomenib
Kura Oncology
Relapsed and/or refractory Acute Myeloid Leukemia
1 trial
Frequently asked questions
How many pipeline programs does Kura Oncology have?
10 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs